For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Wellstat Therapeutics Corporation

USPTO Granted Patents = 62

CIPO Patents = 16

EPO Patents = 18

Trademarks = 7

Forward Citations = 404

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Reid W Von Borstel (41 out of 83 patents)

Shalini Sharma (38 out of 41 patents)

Michael K Bamat (13 out of 34 patents)

4. Stephen D Wolpe (11 out of 16 patents)

5. Kirvin L Hodge (10 out of 12 patents)

6. James Dennen O'Neil (5 out of 5 patents)

7. Irena Tsyrlova (5 out of 9 patents)

8. Ramachandran Arudchandran (4 out of 4 patents)

9. Reid Warren Von Borstel (4 out of 14 patents)

10. Julian Reading (3 out of 4 patents)

11. Fedor Evgenievich Romantsev (3 out of 6 patents)

12. Bradley M Hiltbrand (3 out of 8 patents)

13. David M Simpson (2 out of 11 patents)

14. Dennis Bryan Zerby (2 out of 3 patents)

15. Ming Lu (2 out of 3 patents)

Core Competencies:

Aminoquinazoline Compounds

Benzoic Acid Compounds

Amine Compounds

Stem Cell Mobilization

Metabolic Disorders

Tetrazole Compounds

Mitochondrial Diseases

Pyrimidine Nucleotide Precursors

Acylated Nucleosides

Antimutagenic Compositions

Chemotherapeutic Agent Toxicity

Systemic Inflammation

62 patents: Sort by Forward Citations

1. 10934284 - Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity (2021-03-02),

2. 10085957 - Benzoic acid compounds for reducing uric acid (2018-10-02),

3. 10030015 - Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity (2018-07-24),

4. 9428552 - Stem cell mobilization and tissue repair and regeneration (2016-08-30),

5. 9133073 - Compounds for the treatment of metabolic disorders (2015-09-15),

6. 9115072 - Compounds and method for reducing uric acid (2015-08-25),

7. 8889724 - Tetrazole compounds for reducing uric acid (2014-11-18),

8. 8829058 - Compounds and method for reducing uric acid (2014-09-09),

9. 8703991 - Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids (2014-04-22),

10. 8664433 - Synthesis of 4-[3-(2,6-dimethylbenzyloxy)phenyl]-4-oxobutanoic acid (2014-03-04),

11. 8604083 - Method for the treatment of metabolic disorders (2013-12-10),

12. 8552062 - Methods for the treatment of metabolic disorders such as diabetes (2013-10-08),

13. 8546448 - 3-substituted compounds for reducing uric acid (2013-10-01),

14. 8481595 - Compounds for the treatment of metabolic disorders (2013-07-09),

15. 8410154 - Tetrazole compounds for reducing uric acid (2013-04-02),

Wellstat Therapeutics Corporation is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products. With a commitment to improving patients' lives, Wellstat Therapeutics leverages scientific expertise to advance treatments in various therapeutic areas, including oncology, cardiovascular, and metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

62 Patents

#7 in Rockville, MD

#51 in Maryland

#5,619 in US

#11,340 in the World

Rockville, MD, United States of America

Wellstat Therapeutics Corporation

Forward Citations = 404

36 inventors:

Reid W Von Borstel (41 out of 83 patents)

Shalini Sharma (38 out of 41 patents)

Michael K Bamat (13 out of 34 patents)

4. Stephen D Wolpe (11 out of 16 patents)

5. Kirvin L Hodge (10 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…